| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.78 | 0.003 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.003 |